GB2500585A - Use of oligosaccharides to reduce skin pigmentation - Google Patents

Use of oligosaccharides to reduce skin pigmentation Download PDF

Info

Publication number
GB2500585A
GB2500585A GB1205177.7A GB201205177A GB2500585A GB 2500585 A GB2500585 A GB 2500585A GB 201205177 A GB201205177 A GB 201205177A GB 2500585 A GB2500585 A GB 2500585A
Authority
GB
United Kingdom
Prior art keywords
skin
present
oligosaccharides
pigmentation
skin pigmentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB1205177.7A
Other languages
English (en)
Other versions
GB201205177D0 (en
Inventor
Catherine Anne O'neill
Ralph Paus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manchester
Original Assignee
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manchester filed Critical University of Manchester
Priority to GB1205177.7A priority Critical patent/GB2500585A/en
Publication of GB201205177D0 publication Critical patent/GB201205177D0/en
Priority to EP13721005.0A priority patent/EP2836190B1/en
Priority to KR1020147029528A priority patent/KR102112728B1/ko
Priority to HK15103702.6A priority patent/HK1203147B/en
Priority to PCT/GB2013/050705 priority patent/WO2013140153A2/en
Priority to JP2015500983A priority patent/JP6385334B2/ja
Priority to US14/386,687 priority patent/US10159635B2/en
Priority to ES13721005T priority patent/ES2797535T3/es
Publication of GB2500585A publication Critical patent/GB2500585A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
GB1205177.7A 2012-03-23 2012-03-23 Use of oligosaccharides to reduce skin pigmentation Withdrawn GB2500585A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB1205177.7A GB2500585A (en) 2012-03-23 2012-03-23 Use of oligosaccharides to reduce skin pigmentation
EP13721005.0A EP2836190B1 (en) 2012-03-23 2013-03-19 Cosmetic uses of melibiose or salts thereof.
KR1020147029528A KR102112728B1 (ko) 2012-03-23 2013-03-19 사카라이드의 미용 및 약제학적 용도
HK15103702.6A HK1203147B (en) 2012-03-23 2013-03-19 Cosmetic uses of melibiose or salts thereof
PCT/GB2013/050705 WO2013140153A2 (en) 2012-03-23 2013-03-19 Cosmetic and pharmaceutical uses of saccharides
JP2015500983A JP6385334B2 (ja) 2012-03-23 2013-03-19 糖類の化粧的および医薬的使用
US14/386,687 US10159635B2 (en) 2012-03-23 2013-03-19 Cosmetic and pharmaceutical uses of saccharides
ES13721005T ES2797535T3 (es) 2012-03-23 2013-03-19 Usos cosméticos de melibiosa o sus sales

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1205177.7A GB2500585A (en) 2012-03-23 2012-03-23 Use of oligosaccharides to reduce skin pigmentation

Publications (2)

Publication Number Publication Date
GB201205177D0 GB201205177D0 (en) 2012-05-09
GB2500585A true GB2500585A (en) 2013-10-02

Family

ID=46087042

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1205177.7A Withdrawn GB2500585A (en) 2012-03-23 2012-03-23 Use of oligosaccharides to reduce skin pigmentation

Country Status (7)

Country Link
US (1) US10159635B2 (enExample)
EP (1) EP2836190B1 (enExample)
JP (1) JP6385334B2 (enExample)
KR (1) KR102112728B1 (enExample)
ES (1) ES2797535T3 (enExample)
GB (1) GB2500585A (enExample)
WO (1) WO2013140153A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102020133860A1 (de) 2020-12-16 2022-06-23 MNT Systeme GmbH VERWENDUNG VON β-GALAKTOOLIGOSACCHRIDEN FÜR DIE HERSTELLUNG EINER KOSMETISCHEN UND/ODER PHARMAKOLOGISCH WIRKSAMEN ZUSAMMENSETZUNG
FR3133750B1 (fr) * 2022-03-25 2025-08-29 Helioscience Nouvelles compositions associant des dérivés de chanvre et leur utilisation, notamment en cosmétique
KR102797780B1 (ko) * 2024-11-27 2025-04-21 한국콜마주식회사 천연 원료 조성물 및 이를 포함하는 자외선 차단용 화장료 조성물

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006115A1 (en) * 1998-07-27 2000-02-10 Anderson Jon E Topical compositions containing sialyl sugars and their derivatives
JP2000128770A (ja) * 1998-08-20 2000-05-09 Kanebo Ltd 浴用組成物
JP2003238585A (ja) * 2002-02-08 2003-08-27 Ogawa & Co Ltd ナフトール配糖体およびそれを含有する美白外用剤組成物
US20030186934A1 (en) * 2000-06-28 2003-10-02 Andreas Rathjens Use of inulins and inulin derivatives
WO2004052388A2 (en) * 2002-12-11 2004-06-24 Desert Whale Jojoba Company Composition and method to whiten and exfoliate skin
JP2004224761A (ja) * 2003-01-27 2004-08-12 Ogawa & Co Ltd ナフトール配糖体およびそれを含有する美白外用剤組成物
WO2009081587A1 (ja) * 2007-12-25 2009-07-02 Kao Corporation 皮膚外用剤
CN101999463A (zh) * 2010-10-12 2011-04-06 李国勇 一种用于女性皮肤抗皱与保湿的奶粉

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3082058B2 (ja) * 1992-05-22 2000-08-28 株式会社ホーネンコーポレーション ６−Ｏ−α−Ｄ−ガラクトピラノシル−Ｌ−アスコルビン酸またはその塩およびその製造法並びにその用途
FR2709061B1 (fr) * 1993-08-17 1996-07-19 Ladislas Robert Utilisation d'oligosaccharides dans la prévention et le traitement du vieillissement des tissus.
FR2751876B1 (fr) * 1996-07-31 1998-12-31 Roc Sa Utilisation d'un oligosaccharide comme immunomodulateur, composition dermato-cosmetique et methode de traitement cosmetique
FR2760365B1 (fr) * 1997-03-07 2000-12-22 Roc Sa Composition pharmaceutique ou cosmetologique contenant au moins un retinoide, et methode de traitement cosmetique des modifications liees au vieillissement de la peau et/ou des phaneres
FR2762783B1 (fr) 1997-05-02 2002-09-13 Roc Sa Utilisation d'oligosaccharides pour le traitement du tissu conjonctif et methode de traitement cosmetique mettant en oeuvre ces oligosaccharides
JP3665852B2 (ja) * 1998-03-10 2005-06-29 日本甜菜製糖株式会社 抗アトピー性皮膚炎組成物
JP2002326924A (ja) * 2001-05-07 2002-11-15 Hayashibara Biochem Lab Inc 洗顔料
JP2004224762A (ja) * 2003-01-27 2004-08-12 Ogawa & Co Ltd ナフトール配糖体およびそれを含有する美白外用剤組成物
US20050186168A1 (en) * 2004-02-24 2005-08-25 Albin Eric L. Skin remodeling and regenerative compositions containing elastin peptide ligands having the amino acid sequence (XGXXPG)n
JP2009007261A (ja) * 2007-06-26 2009-01-15 Dainichiseika Color & Chem Mfg Co Ltd 美白剤および化粧料組成物
KR101916489B1 (ko) * 2011-01-07 2018-11-07 알러간, 인코포레이티드 멜라닌 변형 조성물들 및 이의 사용 방법들
JP5570442B2 (ja) * 2011-01-24 2014-08-13 株式会社シャネル化粧品技術開発研究所 水中油型乳化組成物及びその製造方法

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006115A1 (en) * 1998-07-27 2000-02-10 Anderson Jon E Topical compositions containing sialyl sugars and their derivatives
JP2000128770A (ja) * 1998-08-20 2000-05-09 Kanebo Ltd 浴用組成物
US20030186934A1 (en) * 2000-06-28 2003-10-02 Andreas Rathjens Use of inulins and inulin derivatives
JP2003238585A (ja) * 2002-02-08 2003-08-27 Ogawa & Co Ltd ナフトール配糖体およびそれを含有する美白外用剤組成物
WO2004052388A2 (en) * 2002-12-11 2004-06-24 Desert Whale Jojoba Company Composition and method to whiten and exfoliate skin
JP2004224761A (ja) * 2003-01-27 2004-08-12 Ogawa & Co Ltd ナフトール配糖体およびそれを含有する美白外用剤組成物
WO2009081587A1 (ja) * 2007-12-25 2009-07-02 Kao Corporation 皮膚外用剤
CN101999463A (zh) * 2010-10-12 2011-04-06 李国勇 一种用于女性皮肤抗皱与保湿的奶粉

Also Published As

Publication number Publication date
ES2797535T3 (es) 2020-12-02
US20150050224A1 (en) 2015-02-19
GB201205177D0 (en) 2012-05-09
US10159635B2 (en) 2018-12-25
WO2013140153A3 (en) 2015-01-08
WO2013140153A2 (en) 2013-09-26
KR20150031224A (ko) 2015-03-23
EP2836190B1 (en) 2020-04-22
EP2836190A2 (en) 2015-02-18
JP6385334B2 (ja) 2018-09-05
JP2015513357A (ja) 2015-05-11
KR102112728B1 (ko) 2020-05-19
HK1203147A1 (en) 2015-10-23

Similar Documents

Publication Publication Date Title
Mohiuddin Skin aging & modern age anti-aging strategies
Vashi et al. Facial hyperpigmentation: causes and treatment
Hwang et al. Antiaging effects of the mixture of Panax ginseng and Crataegus pinnatifida in human dermal fibroblasts and healthy human skin
Greatens et al. Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible
KR101847957B1 (ko) N-아세틸글루코사민-6-포스페이트를 포함하는 화장 및 약학 조성물
KR20030009454A (ko) 진세노사이드Ｒｂ1으로 된 피부조직 재생촉진제
US20090036545A1 (en) Skin appearance through gene manipulation
JP2000086489A (ja) 老化に対する組成物およびその使用
US20250345265A1 (en) Active principle comprising a particular extract of punica granatum and uses for preventing and/or treating acne
US10159635B2 (en) Cosmetic and pharmaceutical uses of saccharides
KR20170073308A (ko) 피부 개선용 조성물
CN115025001B (zh) 一种具有多重美白祛斑功效的胜肽组合物及其应用
AU2011290175B2 (en) Composition for improving skin quality
CN115154360B (zh) 一种具有美白祛斑及保湿功效的组合物及其应用
CN113440446A (zh) 祛斑组合物及其应用和祛斑护理膜片
US20150290105A1 (en) Composition comprising syringaresinol for improving the skin
JP2011513192A (ja) 皮膚の脱色における使用のためのフルオシノロンアセトニドを含む局所用組成物
HK1203147B (en) Cosmetic uses of melibiose or salts thereof
KR20010075842A (ko) 기능성 식품
Oddos et al. A placebo-controlled study demonstrates the long-lasting anti-aging benefits of a cream containing retinol, dihydroxymethylchromone (DMC) and hyaluronic acid
CN106389141A (zh) 用于改善皮肤的组合物
WO2010137335A1 (ja) α－リポ酸ナノ粒子を含有する、ターンオーバー促進用組成物
US20250177285A1 (en) Banana stem sap compositions and methods of use thereof
KR102308476B1 (ko) 피부 개선용 조성물
RU2446787C2 (ru) Осветляющая кожу композиция для гиперпигментированной кожи

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)